Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours. Lesen Sie weiter auf: FDA Approves New Flu Treatment Quelle: Asthma and Allergy Foundation of America Titelbild/Grafik by […]